• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者的疼痛管理:最新进展

Pain Management in Patients with Multiple Myeloma: An Update.

作者信息

Coluzzi Flaminia, Rolke Roman, Mercadante Sebastiano

机构信息

Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, 04100 Latina, Italy.

Department of Palliative Medicine, Medical Faculty RWTH Aachen University, 52062 Aachen, Germany.

出版信息

Cancers (Basel). 2019 Dec 17;11(12):2037. doi: 10.3390/cancers11122037.

DOI:10.3390/cancers11122037
PMID:31861097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6966684/
Abstract

Most patients with multiple myeloma (MM) suffer from chronic pain at every stage of the natural disease process. This review focuses on the most common causes of chronic pain in MM patients: (1) pain from myeloma bone disease (MBD); (2) chemotherapy-induced peripheral neuropathy as a possible consequence of proteasome inhibitor therapy (i.e., bortezomib-induced); (3) post-herpetic neuralgia as a possible complication of varicella zoster virus reactivation because of post-transplantation immunodepression; and (4) pain in cancer survivors, with increasing numbers due to the success of antiblastic treatments, which have significantly improved overall survival and quality of life. In this review, non-pain specialists will find an overview including a detailed description of physiopathological mechanisms underlying central sensitization and pain chronification in bone pain, the rationale for the correct use of analgesics and invasive techniques in different pain syndromes, and the most recent recommendations published on these topics. The ultimate target of this review was to underlie that different types of pain can be observed in MM patients, and highlight that only after an accurate pain assessment, clinical examination, and pain classification, can pain be safely and effectively addressed by selecting the right analgesic option for the right patient.

摘要

大多数多发性骨髓瘤(MM)患者在自然病程的每个阶段都会遭受慢性疼痛。本综述聚焦于MM患者慢性疼痛的最常见原因:(1)骨髓瘤骨病(MBD)引起的疼痛;(2)蛋白酶体抑制剂治疗(即硼替佐米诱导)可能导致的化疗引起的周围神经病变;(3)由于移植后免疫抑制,水痘带状疱疹病毒再激活可能引发的带状疱疹后神经痛;(4)癌症幸存者的疼痛,随着抗骨髓瘤治疗的成功,癌症幸存者数量增加,这些治疗显著提高了总体生存率和生活质量。在本综述中,非疼痛专科医生将看到一份概述,包括对骨痛中枢敏化和疼痛慢性化潜在生理病理机制的详细描述、在不同疼痛综合征中正确使用镇痛药和侵入性技术的基本原理,以及关于这些主题发布的最新建议。本综述的最终目的是强调MM患者可能出现不同类型的疼痛,并强调只有在进行准确的疼痛评估、临床检查和疼痛分类后,才能通过为合适的患者选择合适的镇痛方案,安全有效地解决疼痛问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b7/6966684/f596398978d5/cancers-11-02037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b7/6966684/f596398978d5/cancers-11-02037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b7/6966684/f596398978d5/cancers-11-02037-g001.jpg

相似文献

1
Pain Management in Patients with Multiple Myeloma: An Update.多发性骨髓瘤患者的疼痛管理:最新进展
Cancers (Basel). 2019 Dec 17;11(12):2037. doi: 10.3390/cancers11122037.
2
[Aggravated post-herpetic neuralgia due to bortezomib].[硼替佐米引起的严重带状疱疹后神经痛]
Rinsho Ketsueki. 2008 May;49(5):331-4.
3
Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline.硼替佐米在多发性骨髓瘤和淋巴瘤中的应用:系统评价和临床实践指南。
Curr Oncol. 2006 Oct;13(5):160-72. doi: 10.3747/co.v13i5.106.
4
Adhesive capsaicin 8% patch for improved control of pain caused by chemotherapy-induced peripheral neuropathy in patients with multiple myeloma: A single-centre, seven-case series.黏附性辣椒素 8%贴片改善多发性骨髓瘤患者化疗引起的周围神经病变相关疼痛的控制:单中心、七例系列研究。
J Oncol Pharm Pract. 2024 Jun;30(4):752-758. doi: 10.1177/10781552241230887. Epub 2024 Feb 28.
5
Gabapentin for chronic neuropathic pain and fibromyalgia in adults.加巴喷丁用于成人慢性神经性疼痛和纤维肌痛。
Cochrane Database Syst Rev. 2014 Apr 27;2014(4):CD007938. doi: 10.1002/14651858.CD007938.pub3.
6
Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia.循证介入疼痛医学,基于临床诊断。17. 带状疱疹和带状疱疹后神经痛。
Pain Pract. 2011 Jan-Feb;11(1):88-97. doi: 10.1111/j.1533-2500.2010.00428.x. Epub 2010 Nov 28.
7
Mechanisms and treatment of bone pain in multiple myeloma.多发性骨髓瘤骨痛的机制与治疗
Curr Opin Support Palliat Care. 2019 Dec;13(4):408-416. doi: 10.1097/SPC.0000000000000467.
8
Herpes zoster--predicting and minimizing the impact of post-herpetic neuralgia.带状疱疹——预测并将带状疱疹后神经痛的影响降至最低
J Antimicrob Chemother. 2001 Feb;47 Suppl T1:1-8. doi: 10.1093/jac/47.suppl_1.1.
9
Postherpetic Neuralgia: Current Evidence on the Topical Film-Forming Spray with Bupivacaine Hydrochloride and a Review of Available Treatment Strategies.带状疱疹后神经痛:盐酸布比卡因贴膜剂的最新证据及现有治疗策略综述。
Adv Ther. 2020 May;37(5):2003-2016. doi: 10.1007/s12325-020-01335-9. Epub 2020 Apr 15.
10
Venlafaxine for neuropathic pain in adults.文拉法辛用于治疗成人神经性疼痛。
Cochrane Database Syst Rev. 2015 Aug 23;2015(8):CD011091. doi: 10.1002/14651858.CD011091.pub2.

引用本文的文献

1
Advances in Supportive Care for Multiple Myeloma-Related Bone Disease-A Review.多发性骨髓瘤相关骨病支持性护理的进展——综述
Cancers (Basel). 2025 Jun 27;17(13):2166. doi: 10.3390/cancers17132166.
2
Role of TRP Channels in Cancer-Induced Bone Pain.瞬时受体电位通道在癌性骨痛中的作用。
Int J Mol Sci. 2025 Jan 30;26(3):1229. doi: 10.3390/ijms26031229.
3
First-Line Combination with Proteasome Inhibitor-Based Treatment and Zoledronic Acid Is Effective in Reducing Later Fractures in Multiple Myeloma Irrespective of Multiple Myeloma Bone Disease at Diagnosis.

本文引用的文献

1
Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.阿片类药物治疗慢性非癌性神经病理性疼痛。一项在至少 4 周的随机安慰剂对照研究中评估疗效、耐受性和安全性的更新系统评价和荟萃分析。
Eur J Pain. 2020 Jan;24(1):3-18. doi: 10.1002/ejp.1494. Epub 2019 Nov 18.
2
Personalized Pain Goals and Responses in Advanced Cancer Patients.晚期癌症患者的个性化疼痛目标和反应。
Pain Med. 2020 Feb 1;21(2):e215-e221. doi: 10.1093/pm/pnz254.
3
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable.
基于蛋白酶体抑制剂的一线联合治疗与唑来膦酸可有效降低多发性骨髓瘤后期骨折风险,无论诊断时是否存在多发性骨髓瘤骨病。
Hematol Rep. 2024 Aug 6;16(3):529-540. doi: 10.3390/hematolrep16030051.
4
Percutaneous vertebroplasty/kyphoplasty contributes to the improved outcome in patients with newly diagnosed multiple myeloma: A single center cohort study.经皮椎体成形术/后凸成形术有助于改善新诊断的多发性骨髓瘤患者的预后:一项单中心队列研究。
J Bone Oncol. 2024 Jun 16;47:100615. doi: 10.1016/j.jbo.2024.100615. eCollection 2024 Aug.
5
Pain Management in Multiple Myeloma Patients: A Literature Review.多发性骨髓瘤患者的疼痛管理:文献综述
Cureus. 2024 Mar 11;16(3):e55975. doi: 10.7759/cureus.55975. eCollection 2024 Mar.
6
Adherence to the evidence-based recommendations in managing bone health, pain, and mobility of patients with multiple myeloma: a mixed method in the Palestinian healthcare system.在巴勒斯坦医疗体系中,采用混合方法评估多发性骨髓瘤患者的骨健康、疼痛和活动能力管理中遵循基于证据的推荐的情况。
BMC Cancer. 2024 Mar 5;24(1):301. doi: 10.1186/s12885-024-12024-z.
7
Conceptualizing an Integrative Multiple Myeloma Care: The Role of Nutrition, Supplements, and Complementary Modalities.概念化综合多发性骨髓瘤护理:营养、补充剂和补充疗法的作用。
Nutrients. 2024 Jan 11;16(2):237. doi: 10.3390/nu16020237.
8
Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.癌症相关的疼痛及其对日常生活的干扰:一项基于人群的 16053 例癌症幸存者和 106345 例无癌症人群的比较研究。
BMC Cancer. 2023 Sep 13;23(1):774. doi: 10.1186/s12885-023-11214-5.
9
Two cases of low back pain of unknown etiology diagnosed as multiple myeloma.两例病因不明的腰痛病例被诊断为多发性骨髓瘤。
SAGE Open Med Case Rep. 2023 Jul 11;11:2050313X231187682. doi: 10.1177/2050313X231187682. eCollection 2023.
10
Metastatic Infiltration of Nervous Tissue and Periosteal Nerve Sprouting in Multiple Myeloma-Induced Bone Pain in Mice and Human.多发性骨髓瘤诱导的小鼠和人骨痛中的神经组织转移浸润和骨膜神经末梢发芽。
J Neurosci. 2023 Jul 19;43(29):5414-5430. doi: 10.1523/JNEUROSCI.0404-23.2023. Epub 2023 Jun 7.
癌症康复者运动指南:国际多学科圆桌会议的共识声明。
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. doi: 10.1249/MSS.0000000000002116.
4
Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.淋巴瘤和多发性骨髓瘤自体造血细胞移植后的生存情况:晚期效应与生活质量
Biol Blood Marrow Transplant. 2020 Feb;26(2):407-412. doi: 10.1016/j.bbmt.2019.10.002. Epub 2019 Oct 9.
5
Tapentadol in the management of cancer pain: current evidence and future perspectives.曲马多在癌症疼痛管理中的应用:当前证据与未来展望。
J Pain Res. 2019 May 16;12:1553-1560. doi: 10.2147/JPR.S191543. eCollection 2019.
6
Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.缓解与活动慢性移植物抗宿主病:对移植后生活质量的影响。
Biol Blood Marrow Transplant. 2019 Sep;25(9):1851-1858. doi: 10.1016/j.bbmt.2019.05.016. Epub 2019 May 24.
7
The Patient with Difficult Cancer Pain.患有难治性癌痛的患者。
Cancers (Basel). 2019 Apr 19;11(4):565. doi: 10.3390/cancers11040565.
8
Interventional Techniques to Management of Cancer-Related Pain: Clinical and Critical Aspects.癌症相关疼痛管理的介入技术:临床与关键要点
Cancers (Basel). 2019 Mar 29;11(4):443. doi: 10.3390/cancers11040443.
9
Bortezomib-induced aerobic glycolysis contributes to chemotherapy-induced painful peripheral neuropathy.硼替佐米诱导的有氧糖酵解有助于化疗引起的痛性周围神经病。
Mol Pain. 2019 Jan-Dec;15:1744806919837429. doi: 10.1177/1744806919837429.
10
Pathophysiology and management of opioid-induced constipation: European expert consensus statement.阿片类药物所致便秘的病理生理学和处理:欧洲专家共识声明。
United European Gastroenterol J. 2019 Feb;7(1):7-20. doi: 10.1177/2050640618818305. Epub 2018 Dec 14.